Investment Summary

Credem Private Equity SGR and Ardian Invest In Vista Vision

On January 1, 2020, private equity firms Credem Private Equity SGR and Ardian invested in healthcare services company Vista Vision

Investment Highlights
  • This is Credem Private Equity SGR’s 1st and Ardian’s 12th transaction in the Healthcare Services sector.
  • This is Credem Private Equity SGR’s 6th and Ardian’s 31st transaction in Italy.

Investment Summary

Date 2020-01-01
Target Vista Vision
Sector Healthcare Services
Investor(s) Credem Private Equity SGR
Ardian
Deal Type Stake Purchase

Target

Vista Vision

Rome, Italy
Vista Vision is a provider of high-quality ophthalmic surgery, specializing in cataract and refractive treatments. Vista Vision was founded in 2003 and is based in Rome, Italy.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 2

DESCRIPTION

Credem Private Equity SGR is the private equity arm of Italian bank, Credito Emiliano Banking Group. The Firm looks to support buyouts and growth capital financings of mid-sized Italian companies. Credem Private Equity SGR is based in Milan.


DEAL STATS #
Overall 6 of 13
Sector: Healthcare Services M&A 1 of 2
Type: Stake Purchase M&A Deals 1 of 2
Country: Italy M&A 6 of 13
Year: 2020 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-11-16 Poplast

Castel San Giovanni, Italy

Poplast is a manufacturer of mono and multi-layer flexible packaging, through the steps of printing, coupling, cutting/packaging of all the flexible and transparent materials, such as polypropylene, polyester, nylon, polyethylene, and aluminum films. Poplast was founded in 1975 and is based in Castel San Giovanni, Italy.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-11-02 BrandOn Group

Naples, Italy

BrandOn Group is a digital company that accelerates access for companies, especially SMEs, to the main international marketplaces, supplying the products and brands of Italian and European groups. BrandOn Group was founded in 2012 and is based in Naples, Italy.

Buy -
Investor

Ardian

Paris, France

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1996
PE ASSETS 127.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Ardian is a mega-sized diversified investment group focused on opportunities worldwide. Ardian invests across and manages funds focused on small and mid-sized buyouts, growth capital financings, mezzanine, infrastructure, real estate, and co-investment opportunities. Ardian's small-buyouts group targets controlling interests in French, German, and Italian businesses valued up to €100 million. It's mid-sized buyout group seeks businesses valued up €1.5 billion and does not have any geographic limitations. The Infrastructure team looks for European opportunities and can commit up to €1 billion per transaction. The Mezzanine group supports junior capital commitments of €5 to €80 million. In addition to direct investing, Ardian also manages various private equity fund-of-funds. Ardian was founded in 1996 and is based in Paris.


DEAL STATS #
Overall 368 of 464
Sector: Healthcare Services M&A 12 of 14
Type: Stake Purchase M&A Deals 38 of 53
Country: Italy M&A 31 of 37
Year: 2020 M&A 1 of 25
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-01 Custom Solutions

France

Custom Solutions specialized in sales promotion and e-logistics. The company's historical core business line is the management of promotional marketing for mass-market brands: payback, deferred bonuses and shops, quizzes and multimedia games. Custom Solutions also provides outsourcing services for POS-A (point of sale advertising) logistics and e-logistics.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-08 Riemser Arzneimittel AG

Greifswald - Insel Riems, Germany

Riemser Arzneimittel AG is a pharmaceutical company focuses on its activities is mainly due to the distribution and life cycle management of pharmaceuticals in therapeutic niche areas with high unmet medical needs. Riemser product range especially covers prescription drugs to treat serious diseases in the therapeutic areas of oncology, infectiology, neurology, in the cardiovascular field, in dermatology, rheumatology, tuberculosis treatment, for the treatment of obesity and primary axillary hyperhidrosis.

Sell -